Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9. (Q38129331)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 17 August 2013

Language	Label	Description	Also known as
English	Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.	scientific article published on 17 August 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

0 references

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Umashankar K Ballehaninna

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Ronald S Chamberlain

2

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

publication date

17 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

3279-3292

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

The epidemiology of pancreatitis and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Proteome-based biomarkers in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

A compendium of potential biomarkers of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Molecular analysis of pancreatic juice: a helpful tool to differentiate benign and malignant pancreatic tumors?

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

European experts consensus statement on cystic tumours of the pancreas

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Proteomic profiling of pancreatic cancer for biomarker discovery

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Stool testing for the early detection of pancreatic cancer: rationale and current evidence

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Progress on molecular markers of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Advances in biomarker research for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Serum Biomarker Panels for the Detection of Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Site-specific activation of AKT protects cells from death induced by glucose deprivation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Molecular markers of pancreatic cancer: development and clinical relevance

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Genetic and epigenetic alterations in pancreatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Molecular pathogenesis of pancreatic cancer: advances and challenges

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Retracted: Activated K-ras and INK4a/Arf Deficiency Cooperate During the Development of Pancreatic Cancer by Activation of Notch and NF-κB Signaling Pathways

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Mouse models of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Exploiting inflammation for therapeutic gain in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Current concepts and novel targets in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

miRNA in clinical practice: pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Diagnostic value of microRNA for pancreatic cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Circulating microRNAs: molecular microsensors in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Molecular pathology and genetics of pancreatic endocrine tumours.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Targeting miR-21 for the therapy of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Mining the malignant ascites proteome for pancreatic cancer biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Strategies for discovering novel pancreatic cancer biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Possible detection of pancreatic cancer by plasma protein profiling

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Proteomics in pancreatic cancer research

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Comprehensive Proteomic Analysis of Human Pancreatic Juice

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Proteomics in pancreatic cancer research

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1033-3

21 January 2018

Advances in pancreatic cancer detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative proteomic analysis of human pancreatic juice: methodological study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CEACAM1, a novel serum biomarker for pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbohydrate markers of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteomic approaches for serum biomarker discovery in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

microRNA signature for human pancreatic cancer invasion and metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TPS and CA 19-9 measurements in the follow-up of patients with pancreatic cancer and chronic pancreatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarker Discovery of Pancreatic and Gastrointestinal Cancer by 2DICAL: 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A method for conducting highly sensitive microRNA in situ hybridization and immunohistochemical analysis in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution and dynamics of pancreatic cancer progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic value of tissue polypeptide specific antigen in patients with pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23949878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-013-1033-3

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38129331&oldid=2201309135"